Prophylactic Effect of Chloroquine and Hydroxychloroquine on COVID-۱۹ Treatment

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 54

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_PBRE-8-2_002

تاریخ نمایه سازی: 10 دی 1402

Abstract:

Background: Severe acute respiratory syndrome coronavirus ۲ (SARS-CoV-۲) is a highly transmissible and pathogenic coronavirus that emerged in late ۲۰۱۹ and has caused a pandemic of acute respiratory disease, named ‘coronavirus disease ۲۰۱۹’ (COVID-۱۹), which has threatened human health and public safety. Objectives: Hydroxychloroquine (HCQ) is an anti-malaria drug with controversial antiviral properties. Some in vitro studies have approved its antiviral effects. Many efforts have been made to prevent and treat COVID-۱۹, but effective drugs for complete eradication of COVID-۱۹ have not been found yet and all available drugs are supportive.  Methods: We tried to review some new aspects of HCQ efficacy in the prevention and treatment of COVID-۱۹ infection. Also, some data from recent clinical trials were studied. It has been shown that HCQ may improve some symptoms of patients, but in severe or critical stages, it did not have significant therapeutic effects and did not reduce the rate of mortality. Results: In this review article, we explained some results of recent studies, including clinical trials on the effects of HCQ on the prevention and treatment of COVID-۱۹ infection. Some studies have revealed HCQ’s beneficial effects in outpatients, and some data showed its hazardous impacts on the heart. The available evidence suggests that CQ or HCQ does not improve clinical outcomes in COVID-۱۹. Well-designed randomized trials are required for assessing the efficacy and safety of HCQ and CQ for COVID.  Conclusion: It was suggested that the dose of HCQ administration must be adjusted and monitored correctly; furthermore, the levels of some myocardial biomarkers, such as troponin must be measured in mild to moderate, severe, and critical infection. Also, combination therapy with other drugs, such as azithromycin may have better anti-inflammatory and antiviral effects.

Authors

Amin Ataie

Department of Toxicology and Pharmacology, School of Medicine, Babol University of Medical Science, Babol, Iran.

Razieh Mansouri

Department of Toxicology and Pharmacology, School of Medicine, Babol University of Medical Science, Babol, Iran.

Hossein Khaleghzadeh-Ahangar

Department of Physiology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.

Ramin Ataee

Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Fatemeh Alibabaei

Department of Toxicology and Pharmacology, School of Medicine, Babol University of Medical Science, Babol, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Yang X, Yu Y, Xu J, Shu H, Xia J, ...
  • Yan Y, Zou Z, Sun Y, Li X, Xu KF, ...
  • Lester RS, Burnham TK, Fine G. Immunologic concepts of light ...
  • Lim HS, Im JS, Cho JY, Bae KS, Klein TA, ...
  • Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, ...
  • GaoJ, TianZ, YangX. Breakthrough: Chloroquine phosphate has shown apparent efficacy ...
  • GautretP, LagierJC, ParolaP, HoangVT, MeddebL, SevestreJ. Clinical and microbiological effect ...
  • Manli Wangetal.Remdesivir and chloroquine effectively inhibit the recently emerged novel ...
  • Chorin E, Wadhwani L, Magnani S. QT interval prolongation and ...
  • Soong TR, Barouch LA, Champion HC. New clinical and ultra-structural ...
  • Cao R, Xu M. Hydroxychloroquine, a less toxic derivative of ...
  • Chen J, Liu D, Liu L, Ping X,Qingnian L. Pilot ...
  • SA MEO, Klonof DC, Akram J. Efficacy of Chloroquine and ...
  • Bergeron E, Vincent MJ, Wickham L, Hamelin J, Basak A, ...
  • Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. ...
  • Loffler BM, Bohn E, Hesse B. Effects of anti-malarial drugs ...
  • Avarino A, Boelaert JR, CassoneA,et al. Effects of chloroquine on ...
  • Hang Zhao, Joyce Wald۱, Michael Palmer, Yuchi Han. Hydroxychloroquine-induced cardiomyopathy ...
  • Felson DT, Anderson JJ and Meen an RF. The comparative ...
  • Frustaci A, Morgante E, Antuzzi D, et al. Inhibition of ...
  • Cervera A .EspinosaG.Font J. IngelmoM.Cardiac toxicity secondary to long term ...
  • Sui J, Li W, Murakami A, Tamin A, Matthews LJ, ...
  • Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, ...
  • Yazdany J, Alfred H.J. Kim. Use of Hydroxychloroquine and Chloroquine ...
  • Vincent, M. J. et al. Chloroquine is a potent inhibitor ...
  • Boule MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, ...
  • Kwok SK, Lee JY, Park SH, Cho ML, Min SY, ...
  • نمایش کامل مراجع